Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Healthy Studies, Infectious Disease, Women's Studies |
| Therapuetic Areas: | Immunology / Infectious Diseases, Other, Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/8/2017 |
| Start Date: | July 2016 |
| End Date: | June 2018 |
This is a minimal risk, anonymous, convenience sample, social behavioral study using
qualitative descriptive survey methods. It is to ascertain community member, physician,
resident and medical student perspectives regarding Human Papillomavirus (HPV) infection,
associated diseases and to identify barriers which prevent these groups from ensuring that
males 9-26 receive the three-shot vaccine series to prevent HPV infection.
The research is focused on these questions:
Do community members understand the ease of transmission of the HPV virus in males 9-26? Do
community members, physicians, residents and medical students have knowledge of the
associated diseases that may occur with the HPV virus infection in males age 9-26? Do
community members, physicians, residents and medical students know the ages in which males
should receive the HPV vaccine three-shot series? What barriers prevent community members
and physicians, residents and medical students from ensuring that males 9-26 receive the
three-shot vaccine series to prevent HPV infection?
qualitative descriptive survey methods. It is to ascertain community member, physician,
resident and medical student perspectives regarding Human Papillomavirus (HPV) infection,
associated diseases and to identify barriers which prevent these groups from ensuring that
males 9-26 receive the three-shot vaccine series to prevent HPV infection.
The research is focused on these questions:
Do community members understand the ease of transmission of the HPV virus in males 9-26? Do
community members, physicians, residents and medical students have knowledge of the
associated diseases that may occur with the HPV virus infection in males age 9-26? Do
community members, physicians, residents and medical students know the ages in which males
should receive the HPV vaccine three-shot series? What barriers prevent community members
and physicians, residents and medical students from ensuring that males 9-26 receive the
three-shot vaccine series to prevent HPV infection?
This is a minimal risk, anonymous, convenience sample, social behavioral study using
qualitative descriptive survey methods. It is to ascertain community member, physician,
resident and medical student perspectives regarding Human Papillomavirus (HPV) infection,
associated diseases and to identify barriers which prevent these groups from ensuring that
males 9-26 receive the three-shot vaccine series to prevent HPV infection.
The research is focused on these questions:
Do community members understand the ease of transmission of the HPV virus in males 9-26? Do
community members, physicians, residents and medical students have knowledge of the
associated diseases that may occur with the HPV virus infection in males age 9-26? Do
community members, physicians, residents and medical students know the ages in which males
should receive the HPV vaccine three-shot series? What barriers prevent community members
and physicians, residents and medical students from ensuring that males 9-26 receive the
three-shot vaccine series to prevent HPV infection?
qualitative descriptive survey methods. It is to ascertain community member, physician,
resident and medical student perspectives regarding Human Papillomavirus (HPV) infection,
associated diseases and to identify barriers which prevent these groups from ensuring that
males 9-26 receive the three-shot vaccine series to prevent HPV infection.
The research is focused on these questions:
Do community members understand the ease of transmission of the HPV virus in males 9-26? Do
community members, physicians, residents and medical students have knowledge of the
associated diseases that may occur with the HPV virus infection in males age 9-26? Do
community members, physicians, residents and medical students know the ages in which males
should receive the HPV vaccine three-shot series? What barriers prevent community members
and physicians, residents and medical students from ensuring that males 9-26 receive the
three-shot vaccine series to prevent HPV infection?
Community Participants
Inclusion
All visitors to the Pediatric or Internal Medicine University Health Shreveport Clinics
willing to complete a survey
Community Study Exclusion
Those do not wish to participate in the study
Those who English is not their first language
Clinical Faculty, Resident, and Medical Student Study
Inclusion
All Louisiana State University Shreveport Health Clinical Faculty, Resident, and Medical
Student Inclusion willing to to complete the online survey.
Clinical Faculty, Resident, and Medical Student Study
Exclusion
Any LSU Health Shreveport Clinical Faculty, Resident, and Medical Student which declines
to take the survey or do not attempt to complete it.
We found this trial at
1
site
Click here to add this to my saved trials
